Itron (ITRI) Cash & Equivalents (2009 - 2026)

Itron has reported Cash & Equivalents for 18 years, with the latest figure at $712.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 36.54% year-over-year to $712.8 million; the trailing twelve-month figure through Mar 2026 stood at $712.8 million (down 36.54% YoY), and the FY2025 full-year result was $1.0 billion, down 2.93% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $712.8 million, down from $1.0 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $1.3 billion in Q3 2025, with the low at $196.0 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $616.7 million across 5 years, with a median of $302.0 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 64.5% — and 2024, when it jumped 295.49%.
• Itron's Cash & Equivalents stood at $202.0 million in 2022, then jumped by 49.52% to $302.0 million in 2023, then soared by 248.04% to $1.1 billion in 2024, then declined by 2.93% to $1.0 billion in 2025, then tumbled by 30.14% to $712.8 million in 2026.
• The last three Cash & Equivalents figures came in at $712.8 million (Q1 2026), $1.0 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.